Vice President, Growth
Langland, A Publicis Health Company
Sarah McKeown-Cannon is VP, Growh at Langland’s US location, which specializes in Clinical Trial Experience (CTE). She helps sponsors deliver innovative recruitment and retention solutions that provide measurable results, enriching study experiences by turning healthcare intelligence into creative engagement and putting the patient at the forefront of every clinical trial. Originally based in the UK, Sarah has been an integral part of Langland’s Clinical Trial Experience team since 2015. She moved across the pond in 2016 to open a Langland’s New York office, where she now leads the development of global clinical trial programs across therapy areas from oncology, cardiovascular to rare disease and everything in between. Driven by making a difference in peoples’ lives, Sarah and her team develop recruitment and retention initiatives by combining innovation with a keen focus on the patient and site perspective. In doing so, she continuously delivers bespoke strategies and campaigns that bring big results, encouraging clients to always think further.